- Home
- BBW vs NKTR Comparison
BBW vs NKTR Comparison
Compare BBW & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBW
- NKTR
- Stock Information
- Founded
- BBW 1997
- NKTR 1990
- Country
- BBW United States
- NKTR United States
- Employees
- BBW N/A
- NKTR 61
- Industry
- BBW Recreational Games/Products/Toys
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- BBW Consumer Discretionary
- NKTR Health Care
- Exchange
- BBW Nasdaq
- NKTR Nasdaq
- Market Cap
- BBW 672.6M
- NKTR 948.8M
- IPO Year
- BBW 2004
- NKTR 1994
- Fundamental
- Price
- BBW $71.61
- NKTR $51.07
- Analyst Decision
- BBW Strong Buy
- NKTR Strong Buy
- Analyst Count
- BBW 5
- NKTR 6
- Target Price
- BBW $68.80
- NKTR $81.67
- AVG Volume (30 Days)
- BBW 454.2K
- NKTR 1.2M
- Earning Date
- BBW 08-28-2025
- NKTR 11-06-2025
- Dividend Yield
- BBW 1.22%
- NKTR N/A
- EPS Growth
- BBW 25.62
- NKTR N/A
- EPS
- BBW 4.47
- NKTR N/A
- Revenue
- BBW $522,518,000.00
- NKTR $74,934,000.00
- Revenue This Year
- BBW $10.77
- NKTR N/A
- Revenue Next Year
- BBW $1.53
- NKTR N/A
- P/E Ratio
- BBW $16.20
- NKTR N/A
- Revenue Growth
- BBW 8.10
- NKTR N/A
- 52 Week Low
- BBW $30.49
- NKTR $6.48
- 52 Week High
- BBW $75.85
- NKTR $52.75
- Technical
- Relative Strength Index (RSI)
- BBW 63.51
- NKTR 85.95
- Support Level
- BBW $71.14
- NKTR $42.12
- Resistance Level
- BBW $75.85
- NKTR $50.53
- Average True Range (ATR)
- BBW 4.14
- NKTR 3.47
- MACD
- BBW 0.72
- NKTR 1.32
- Stochastic Oscillator
- BBW 74.99
- NKTR 93.25
About BBW Build-A-Bear Workshop Inc.
Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.